Accessibility Menu
 
Maternus-Kliniken Aktiengesellschaft logo

Maternus-Kliniken Aktiengesellschaft

(ETR) MAK

Current Price$1.16
Market Cap$28.10M
Since IPO (1992)-67%
5 Year-72%
1 Year-21%
1 Month+23%

Maternus-Kliniken Aktiengesellschaft Financials at a Glance

Market Cap

$28.10M

Revenue (TTM)

$284.18M

Net Income (TTM)

$22.40M

EPS (TTM)

$-0.64

P/E Ratio

-2.09

Dividend

$0.00

Beta (Volatility)

0.03 (Low)

Price

$1.16

Volume

7,439

Open

$1.30

Previous Close

$1.16

Daily Range

$1.16 - $1.35

52-Week Range

$0.89 - $10.90

MAK News

No articles available.

MAK: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Maternus-Kliniken Aktiengesellschaft

Industry

Healthcare Providers and Services

Employees

1,903

CEO

Mario Augusto Ruano-Wohlers

Headquarters

Berlin, 10117, DE

MAK Financials

Key Financial Metrics (TTM)

Gross Margin

26%

Operating Margin

13%

Net Income Margin

-9%

Return on Equity

0%

Return on Capital

40%

Return on Assets

-11%

Earnings Yield

-47.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$28.10M

Shares Outstanding

20.97M

Volume

7.44K

Short Interest

0.00%

Avg. Volume

1.96K

Financials (TTM)

Gross Profit

$98.78M

Operating Income

$3.99M

EBITDA

$10.71M

Operating Cash Flow

$15.07M

Capital Expenditure

$1.22M

Free Cash Flow

$13.86M

Cash & ST Invst.

$4.94M

Total Debt

$165.41M

Maternus-Kliniken Aktiengesellschaft Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$118.60M

+133.8%

Gross Profit

$35.80M

+485.5%

Gross Margin

30.19%

N/A

Market Cap

$28.10M

N/A

Market Cap/Employee

$19.35K

N/A

Employees

1,452

N/A

Net Income

$4.20M

+54.4%

EBITDA

$13.00M

+1394.8%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$2.18M

+101.3%

Accounts Receivable

$8.72M

+34.2%

Inventory

$408.00K

-30.4%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-11.31%

N/A

Return on Invested Capital

40.18%

N/A

Free Cash Flow

$2.23M

+152.3%

Operating Cash Flow

$3.41M

+196.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AAQ1.DEaap Implantate AG
$1.38+0.73%
NN6.DENanoRepro AG
$1.42-0.35%
GME.DEGeratherm Medical AG
$2.80+0.00%
M3V.DEMeVis Medical Solutions AG
$22.80+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
EEIQEpicQuest Education Group International
$8.44+2.09%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.92+0.08%
INTCIntel
$44.10-0.07%

Questions About MAK

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.